Amifampridine Alternatives Compared
| Amifampridine | Firdapse (amifampridine) | Ruzurgi (amifampridine) |
|
|---|
| Amifampridine | Firdapse (amifampridine) | Ruzurgi (amifampridine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Lambert-Eaton Myasthenic Syndrome. Amifampridine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lambert-Eaton Myasthenic Syndrome. Firdapse may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lambert-Eaton Myasthenic Syndrome. Ruzurgi may also be used for purposes not listed in this medication guide. |
||||||||
| More about Amifampridine | More about Firdapse (amifampridine) | More about Ruzurgi (amifampridine) | ||||||||
| Ratings & Reviews | ||||||||||
|
Amifampridine has an average rating of 4.7 out of 10 from a total of 6 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 50% reported a negative effect. |
Firdapse has an average rating of 1.0 out of 10 from a total of 3 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Ruzurgi has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Amifampridine side effects |
View all Firdapse side effects |
View all Ruzurgi side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Firdapse prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
| Firdapse, Ruzurgi | Other amifampridine brands include: Ruzurgi | Other amifampridine brands include: Firdapse | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
2.5 hours |
2.5 hours |
2.5 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 202 drugs are known to interact with Amifampridine:
|
A total of 202 drugs are known to interact with Firdapse:
|
A total of 202 drugs are known to interact with Ruzurgi:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
November 28, 2018 |
November 28, 2018 |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.